BioSpace News Archive

Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been recognized as a Leader in the IDC MarketScape for Life Science Drug Safety Services, Worldwide1.

XLCS Partners, Inc., a leading middle market investment bank, is pleased to announce that it served as exclusive advisor to MEDEFAB in its acquisition by Molded Devices, Inc..

SkyWater Technology, the innovator’s trusted foundry partner, announced its partnership with MGI (a member of BGI Group) to supply critical components used by MGI’s DNA sequencing system DNBSEQ-T7, one of the first officially approved products by the National Medical Products Administration (NMPA – essentially China’s version of the FDA), under the emergency approval process for the coronavirus (COVID-19).

Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its increased commitment to the global fight against COVID-19 by making available zero cost samples of the company’s proprietary technologies to developers and manufacturers of molecular assays for COVID-19 detection

What’s New: In a joint paper published in Nature Machine Intelligence, researchers from Intel Labs and Cornell University demonstrated the ability of Intel’s neuromorphic research chip, Loihi, to learn and recognize hazardous chemicals in the presence of significant noise and occlusion.

H4D, a leading global telemedicine company, is joining the international effort to fight the global coronavirus pandemic. H4D is providing hospitals with a fast, efficient and reliable solution to improve patient flow management in the emergency department

EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, today announced that the prestigious peer-reviewed journal Cancer Cell has published a scientific paper, authored by EnGeneIC’s research team, entitled “Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocell.”

In addition to our industry-leading safety and quality standards across all three of our care divisions, AIS Healthcare is implementing additional measures in response to COVID-19.

The National Kidney Registry (NKR) and Viracor Eurofins announced a partnership today to deliver testing for Coronavirus SARS-CoV-2 (the virus that causes COVID-19 disease) to NKR’s vast network of Member Centers

The UNC Medical Center McLendon Clinical Laboratories in Chapel Hill have developed a diagnostic test for coronavirus disease 2019 based on a World Health Organization assay. The UNC test is now in use at the medical center in Chapel Hill, NC.